Chris Storgard
Chief Tech/Sci/R&D Officer chez HERON THERAPEUTICS, INC.
Profil
Chris M.
Storgard is currently the Chief Medical Officer at Heron Therapeutics, Inc. He previously served as the Vice President-Clinical Research & Development at Ardea Biosciences, Inc. from 2013 to 2016 and as the Chief Medical Officer at Fate Therapeutics, Inc. from 2016 to 2018.
Prior to that, he was a Member & Assistant Professor at Mayo Medical School from 2001 to 2004.
Dr. Storgard holds a doctorate degree from the University of Saskatchewan.
Postes actifs de Chris Storgard
| Sociétés | Poste | Début |
|---|---|---|
| HERON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/11/2018 |
Anciens postes connus de Chris Storgard
| Sociétés | Poste | Fin |
|---|---|---|
| FATE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 05/11/2018 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Chief Tech/Sci/R&D Officer | 02/01/2016 |
| Mayo Medical School | Corporate Officer/Principal | 02/01/2004 |
Formation de Chris Storgard
| University of Saskatchewan | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| FATE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Health Technology |
